[uam_ad id="317182"]

RIO DE JANEIRO, BRAZIL - Developed by Oxford University in partnership with pharmaceutical company AstraZeneca, the vaccine against Covid-19 could finalize its human trials in September, according to Sarah Gilbert, the scientist behind the studies at the British university.

The immunizer - considered the most advanced in the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?